​​Stages of Alcoholism: Signs, Symptoms, and How to Get Help

The four stages of alcoholism progress from social drinking to end-stage alcohol use disorder, where chronic organ damage, severe physical dependence, and life-threatening withdrawal become the defining clinical features.

Alcoholism does not develop overnight. It follows a predictable trajectory identified by researcher E. Morton Jellinek, whose work in the 1950s formalized how casual drinking escalates through tolerance, dependence, and finally severe alcohol use disorder (AUD).

Understanding each stage, and recognizing when drinking has crossed from one to the next, is the first step toward getting help before irreversible damage occurs.

Key Takeaways

• According to the National Institute on Alcohol Abuse and Alcoholism, approximately 14.5 million Americans aged 12 and older met criteria for alcohol use disorder in 2019, with end-stage cases representing the most treatment-resistant and medically complex subset of this population.
• E. Morton Jellinek’s 1952 model identifies four progressive stages of alcohol use disorder (pre-alcoholic, early alcoholic, middle alcoholic, and end-stage chronic), each defined by escalating GABA-A receptor adaptation and dopaminergic reward pathway disruption.
• The DSM-5 diagnoses alcohol use disorder on an 11-criterion spectrum: meeting 2 to 3 criteria constitutes mild AUD, 4 to 5 constitutes moderate AUD, and 6 or more constitutes severe AUD corresponding to middle and end-stage alcoholism.
• Wernicke-Korsakoff syndrome, hepatic cirrhosis, and alcoholic cardiomyopathy are the three most clinically significant complications of end-stage alcohol use disorder and are direct drivers of mortality.
• According to Schuckit (2014) in the New England Journal of Medicine, untreated delirium tremens carries a mortality rate of 15 to 20%, reduced to below 1% with benzodiazepine-based clinical management under the CIWA-Ar protocol.

What Are the Stages of Alcoholism?

Alcoholism progresses through four clinically distinct stages, each defined by escalating GABA-A receptor adaptation, increasing DSM-5 diagnostic criteria, and mounting physical consequences that become progressively harder to reverse without treatment.

The Jellinek Model: Four Stages of Alcoholism

E. Morton Jellinek published “Phases of Alcohol Addiction” in 1952 following large-scale studies of individuals with alcohol use disorder. His model identified four progressive phases (pre-alcoholic, early alcoholic, middle or crucial alcoholic, and late or chronic alcoholic) collectively visualized as the Jellinek Curve.

While some simplified frameworks condense alcoholism into three stages, the four-stage Jellinek model remains the most widely referenced clinical framework for understanding how alcohol use disorder develops and progresses. The Jellinek Curve illustrates both the descent into alcohol use disorder and the upward trajectory into recovery.

How Alcohol Use Disorder Is Diagnosed

The DSM-5 diagnoses alcohol use disorder using 11 criteria evaluated over a 12-month period. Meeting 2 to 3 criteria constitutes mild AUD. Meeting 4 to 5 criteria constitutes moderate AUD. Meeting 6 or more criteria constitutes severe AUD, corresponding to what is clinically described as the middle to end stages of alcoholism.

The criteria cover inability to control intake, failed obligations, craving, withdrawal symptoms, tolerance, continued use despite physical or psychological harm, and time lost to alcohol-related activity. Individuals in end-stage alcoholism routinely meet most or all 11 criteria simultaneously.

How Alcoholism Progresses: Tolerance, Dependence, and GABA-A Adaptation

Alcoholism progresses through a neurochemical cascade driven by GABA-A receptor downregulation and dopaminergic terminal depletion, advancing from tolerance to physical dependence severe enough to make cessation medically dangerous without supervision.

GABA-A Receptor Downregulation and Tolerance

Alcohol potentiates gamma-aminobutyric acid (GABA) at GABA-A receptors, producing sedation and anxiolysis. Chronic alcohol exposure causes the brain to compensate by downregulating GABA-A receptor density and sensitivity, reducing inhibitory signaling below its natural baseline.

This downregulation drives tolerance, the need for increasing alcohol quantities to achieve the same effect. It is also the core mechanism that transitions social drinking into compulsive alcohol use. As GABA-A receptors adapt, excitatory glutamate signaling simultaneously becomes sensitized through NMDA receptor upregulation, creating a state where alcohol is required to suppress neural hyperexcitability. Cessation in this state triggers alcohol withdrawal driven by this GABA-glutamate rebound imbalance.

Dopaminergic Terminal Depletion and Loss of Reward

Alcohol acutely increases dopamine release in the nucleus accumbens, reinforcing drinking through positive reward signaling. With repeated heavy use, dopaminergic terminals in the nucleus accumbens undergo progressive depletion, reducing the brain’s capacity for natural reward.

This depletion drives the shift from drinking for pleasure to drinking to prevent withdrawal. At middle and end-stage alcoholism, alcohol no longer produces meaningful reward but functions primarily to suppress withdrawal-driven dysphoria. GABA-A rebound hyperexcitability at this point generates alcohol withdrawal seizures when alcohol is removed abruptly without clinical management.

The 4 Stages of Alcoholism: Signs at Each Stage

The table below summarizes the clinical profile of each stage of the Jellinek Model across drinking pattern, physical signs, psychological signs, and DSM-5 severity.

Stage	Drinking Pattern	Physical Signs	Psychological Signs	DSM-5 Severity
1 Pre-Alcoholic	Social and relief drinking	Developing tolerance, mild hangovers	Increased cravings, using alcohol to cope	0-1 criteria
2 Early Alcoholic	Frequent, secretive drinking; blackouts begin	Morning shakiness, digestive disruption	Denial, guilt, hiding intake	2-3 (mild AUD)
3 Middle Alcoholic	Daily drinking; loss of control episodes	Liver enlargement, withdrawal symptoms between drinks	Abandoning responsibilities, relationship breakdown	4-5 (moderate AUD)
4 End-Stage/Chronic	Continuous drinking to prevent withdrawal	Cirrhosis, cardiomyopathy, neuropathy, cognitive impairment	Complete loss of control, obsessive preoccupation with alcohol	6-11 (severe AUD)

1- Stage 1: Pre-Alcoholic Phase

In the pre-alcoholic phase, drinking appears entirely social or recreational. Alcohol tolerance is developing, but the drinker rarely recognizes it as a problem. The key clinical signal at this stage is drinking for psychological relief: using alcohol to reduce anxiety, social discomfort, or emotional pain rather than purely for pleasure.

Patterns associated with this stage include binge drinking episodes at social events, increasing drinking frequency to manage stress, and tolerance that rises noticeably compared to non-drinking peers. No DSM-5 criteria are typically met, but GABA-A receptor adaptation is already beginning to lay the neurochemical foundation for alcohol use disorder.

2- Stage 2: Early Stages of Alcoholism

The early stages of alcoholism are marked by the first uncontrolled drinking episodes, including blackouts in which the drinker remains conscious but cannot form new memories. Hippocampal long-term potentiation is suppressed by alcohol at high blood concentrations, producing these memory gaps. Denial and rationalization become prominent coping strategies.

Drinkers in the early stages begin hiding intake, lying about consumption, and experiencing morning-after anxiety or shakiness briefly relieved by alcohol. Two to three DSM-5 criteria are typically met, qualifying as mild alcohol use disorder. Without intervention, the early stages of alcoholism reliably progress to the middle phase.

3- Stage 3: Middle Alcoholic Phase

The middle alcoholic phase is the point where alcohol use disorder becomes visible to others. Daily drinking is common, often beginning in the morning to prevent withdrawal discomfort. Physical signs including facial puffiness, broken capillaries, weight changes, and early hepatic enlargement become apparent.

At this stage, the individual cannot reliably predict or control the amount consumed once drinking begins. Occupational and relational consequences accumulate, and the drinker may make repeated unsuccessful attempts to cut down. Four to five DSM-5 criteria are typically met, qualifying as moderate alcohol use disorder.

4- Stage 4: Late-Stage and End-Stage Alcoholism

Late-stage and end-stage alcoholism is characterized by continuous or near-continuous alcohol consumption, not for pleasure but to suppress severe withdrawal. The individual’s daily life is organized entirely around obtaining and consuming alcohol. Six or more DSM-5 criteria are consistently met, qualifying as severe alcohol use disorder.

Physical organ damage at the late and end stage is often irreversible without medical intervention. End-stage alcoholism carries the highest mortality risk of any stage, driven by hepatic failure, cardiovascular collapse, and the life-threatening complications of abrupt cessation without clinical supervision.

End-Stage Alcoholism: What Happens to the Body

End-stage alcoholism produces systematic organ damage across hepatic, cardiovascular, neurological, and immune systems, with mortality risk from multiple concurrent complications compounding as the disease progresses without treatment.

Liver Damage: From Fatty Liver to Cirrhosis

Chronic alcohol exposure drives a predictable hepatic injury sequence. Fatty liver disease (hepatic steatosis) develops first, as alcohol impairs hepatic lipid metabolism and acetaldehyde accumulation disrupts mitochondrial function. Fatty liver is reversible with abstinence.

Alcoholic hepatitis follows with sustained heavy drinking, producing hepatocyte inflammation and necrosis. In end-stage alcoholism, hepatic stellate cell activation drives progressive fibrosis, depositing dense collagen that replaces functional liver tissue. Full cirrhosis produces portal hypertension, ascites, and esophageal varices, representing irreversible structural damage that substantially elevates mortality risk.

Neurological Damage: Wernicke-Korsakoff Syndrome

Chronic alcohol use disrupts thiamine (vitamin B1) absorption through poor dietary intake, impaired gastrointestinal absorption, and reduced hepatic storage. Severe thiamine deficiency precipitates Wernicke’s encephalopathy, an acute neurological emergency characterized by confusion, oculomotor dysfunction, and ataxia.

Untreated Wernicke’s encephalopathy progresses to Korsakoff syndrome, a chronic amnestic condition defined by severe anterograde and retrograde memory impairment, confabulation, and personality changes. This progression constitutes alcoholic dementia and may be irreversible even with complete abstinence.

Cardiovascular and Immune System Damage

Alcoholic cardiomyopathy develops through direct myocardial toxicity from acetaldehyde and oxidative stress. These substances damage cardiomyocytes, impairing contractile function and producing ventricular dilation. End-stage cardiomyopathy presents as congestive heart failure with reduced ejection fraction, arrhythmias, and progressive cardiac decompensation.

Alcohol suppresses neutrophil recruitment and cytokine signaling, fundamentally weakening immune defense. End-stage individuals are significantly more susceptible to pneumonia, tuberculosis, and bacterial peritonitis. These infections carry disproportionately high mortality in this population due to concurrent hepatic and nutritional impairment.

End-Stage Withdrawal: Delirium Tremens and Seizures

Withdrawal in end-stage alcoholism is a medical emergency. GABA-A receptor downregulation and NMDA receptor sensitization produce severe rebound hyperexcitability when alcohol is removed. Alcohol withdrawal hallucinations typically emerge 12 to 24 hours after the last drink. Delirium tremens, characterized by severe confusion, hyperthermia, cardiovascular instability, and seizures, emerges 24 to 72 hours after cessation.

Untreated delirium tremens carries a mortality rate of 15 to 20%. With the CIWA-Ar protocol and benzodiazepine-based withdrawal management in a monitored clinical setting, mortality reduces to below 1%. This difference underscores why end-stage alcoholism requires medically supervised detoxification rather than self-managed cessation.

Treatment for Alcohol Use Disorder at The Grove Estate

The Grove Estate Addiction Treatment provides medically supervised residential care for adults with alcohol use disorder at all stages of the disease, from the early stages through end-stage alcoholism, at its Indiana facility.

1- Medical Detox

Medical detox at The Grove Estate provides 24-hour physician-monitored withdrawal management for individuals with physical alcohol dependence. For end-stage cases, supervised detox using the CIWA-Ar protocol prevents progression from alcohol withdrawal to delirium tremens, managing the acute phase safely before residential treatment begins.

2- Residential Alcohol Addiction Treatment

The alcohol addiction residential program delivers structured 24-hour clinical care combining Cognitive Behavioral Therapy, Dialectical Behavior Therapy, and individualized treatment planning for adults across all stages of alcohol use disorder. Residential care removes alcohol access while the brain’s GABA-A receptors begin receptor resensitization, reducing relapse risk during the highest-vulnerability early abstinence window.

Frequently Asked Questions

What Are the Five Stages of Alcoholism?

Five-stage models expand the Jellinek four-stage framework by splitting the pre-alcoholic phase into separate “social drinking” and “relief drinking” sub-stages, producing: social, relief, early, middle, and end-stage. Others add recovery as a fifth stage. The DSM-5 does not define stages numerically. It classifies alcohol use disorder as mild, moderate, or severe based on the number of diagnostic criteria met in a 12-month period. 

What Are the 7 Stages of Alcoholism?

Seven-stage models subdivide the Jellinek Curve into: social drinking, early problem drinking, middle dependence, chronic dependence, crisis or rock bottom, active recovery, and sustained recovery. These are used in psychoeducation rather than clinical diagnosis. Formal clinical assessment uses the DSM-5 eleven-criterion framework, which does not define stages numerically or require reaching a “rock bottom” before treatment eligibility.

What Are the 4 Levels of Alcoholism?

The four levels correspond directly to the Jellinek Model’s four stages: pre-alcoholic (tolerance developing, 0-1 DSM-5 criteria), early alcoholic (mild AUD, 2-3 criteria), middle alcoholic (moderate AUD, 4-5 criteria), and late or chronic alcoholic (severe AUD, 6 or more criteria). Each level is distinguished by escalating physical dependence, loss of control, and organ involvement. 

What Are the 7 Stages of Drinking?

The 7 stages of drinking refer to Blood Alcohol Concentration effect stages: sobriety (below 0.05%), euphoria (0.03 to 0.12%), excitement (0.09 to 0.25%), confusion (0.18 to 0.30%), stupor (0.25 to 0.40%), coma (0.35 to 0.50%), and death (above 0.45%). These describe acute intoxication effects at specific BAC levels, not the long-term progression of alcohol use disorder described by the Jellinek stages. 

References

1. National Institute on Alcohol Abuse and Alcoholism. (2023). Alcohol use disorder. U.S. Department of Health and Human Services. https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-use-disorder
2. National Institute on Alcohol Abuse and Alcoholism. (2023). Alcohol facts and statistics. https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/alcohol-facts-and-statistics
3. National Institute on Drug Abuse. (2023). Alcohol research. https://nida.nih.gov/research-topics/alcohol
4. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Publishing.
5. Jellinek, E. M. (1952). Phases of alcohol addiction. Quarterly Journal of Studies on Alcohol, 13(4), 673-684.
6. Victor, M., Adams, R. D., & Collins, G. H. (1989). The Wernicke-Korsakoff Syndrome. F.A. Davis.
7. Schuckit, M. A. (2014). Recognition and management of withdrawal delirium (delirium tremens). New England Journal of Medicine, 371(22), 2109-2113.
8. Lieber, C. S. (2003). Relationships between nutrition, alcohol use, and liver disease. Alcohol Research and Health, 27(3), 220-231.